|
SNX7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.238050E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.634830E-01 |
| Normal-vs-Stage2 |
8.009900E-04 |
| Normal-vs-Stage3 |
4.933200E-01 |
| Normal-vs-Stage4 |
9.571600E-01 |
| Stage1-vs-Stage2 |
1.411760E-02 |
| Stage1-vs-Stage3 |
6.129400E-01 |
| Stage1-vs-Stage4 |
3.303800E-01 |
| Stage2-vs-Stage3 |
1.611600E-02 |
| Stage2-vs-Stage4 |
7.623600E-03 |
| Stage3-vs-Stage4 |
6.295200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.093000E-01 |
| Normal-vs-AfricanAmerican |
1.851360E-01 |
| Normal-vs-Asian |
7.419600E-01 |
| Caucasian-vs-AfricanAmerican |
7.291800E-02 |
| Caucasian-vs-Asian |
6.053600E-01 |
| AfricanAmerican-vs-Asian |
2.160200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.916800E-01 |
| Normal-vs-Female |
9.738000E-02 |
| Male-vs-Female |
5.263400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.606600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.125900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.260380E-01 |
| Normal-vs-Age(81-100Yrs) |
8.509800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.671200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.456200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.329400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.246400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.581400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.209200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.313650E-02 |
| Classical-VS-Follicular |
2.12050044190448E-10 |
| Classical-VS-Other |
7.672400E-01 |
| Classical-VS-Normal |
8.582600E-01 |
| Tall-VS-Follicular |
1.11910000044624E-07 |
| Tall-VS-Other |
2.593400E-01 |
| Tall-VS-Normal |
7.098400E-02 |
| Follicular-VS-Other |
1.024440E-01 |
| Follicular-VS-Normal |
4.74439999953447E-07 |
| Other-VS-Normal |
8.115600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.282270E-03 |
| Normal-vs-N1 |
1.701800E-01 |
| N0-vs-N1 |
3.604600E-01 |
|
|
